Application for quotation of securities - CHM

Aug 6, 2026 at 10:04 PM EDT · Issued by Chimeric Therapeutics Limited via ASX

Filed with ASX · Aug 6, 2026 at 10:04 PM EDT · 6 pages · English

On 6ix: 6ix.com/news/application-for-quotation-of-securities-chm-5

Release

Appendix 2A - Application for quotation of securities Appendix 2A - Application for quotation of securities 1 / 6 Announcement Summary Entity name CHIMERIC THERAPEUTICS LIMITED Announcement Type New announcement Date of this announcement Friday August 07, 2026 The +securities to be quoted...

Chimeric Therapeutics Limited on 6ix

Earlier from Chimeric Therapeutics

Quarterly Activities/Appendix 4C Cash Flow ReportJul 31
Chimeric receives $1.62M advance on FY26 R&D tax incentiveJul 29
Investor PresentationJul 27
CHM CDH17 Phase 1 clinical trial update - New DL 3 dataJul 15
Appointment of Financial Adviser for Strategic ReviewJun 30

Later from Chimeric Therapeutics

Trading HaltAug 16
CHM ceases enrolment in Phase 1 trial and Company updateAug 18
Appendix 4E and Preliminary Final ReportAug 31
FY2026 Annual Report, creditor update and Board changesSep 30
Initial Director's Interest Notice - RMOct 5

All Chimeric Therapeutics news releases

Follow Chimeric Therapeutics into a list and get an email when it puts out news.

Follow Chimeric Therapeutics